Dr Reddys Laboratories Share Price Today - Live Blog for October 24, 2025

Dr Reddys Laboratories Ltd experienced a substantial 0.08% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,285.00, making it an appealing option for investors.

Dr Reddys Laboratories Ltd share price surged by 0.13%. With its current market price standing at ₹1,285.05 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.48% drop, and it's now trading at ₹1,280.80 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd witnessed a -0.01% decrease in its share price, and it is currently trading at ₹1,285.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.6000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Following a noteworthy 0.59% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,285.85. When it comes to valuation, this stock has a PE ratio of 18.6000, with the industry PE ratio at 35.3139.

The stock of Dr Reddys Laboratories Ltd is facing a -0.07% decline and is currently trading at ₹1,278.40 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd witnessed a -0.20% decrease in its share price, and it is currently trading at ₹1,277.95. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.6000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.13%, reaching a current market price of ₹1,279.95. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has dropped by -0.14%, a development that warrants careful analysis. Presently trading at ₹1,280.90, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd experienced a -0.04% dip in its share price and is currently trading at ₹1,282.70. The stock has a PE ratio of 18.6000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% decline, and it currently trades at ₹1,283.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

After a significant 0.24% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,283.45 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.03% uptick in its share price. As a result, it's now actively trading at ₹1,280.70 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.07%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,279.80, and market participants are assessing the implications. The stock has a PE ratio of 18.6000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.19% boost, with the current market value at ₹1,280.75 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd share price surged by 0.09%. With its current market price standing at ₹1,278.35 per share, this stock is garnering increased attention from the investment community.

Following a noteworthy 0.11% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,277.95. When it comes to valuation, this stock has a PE ratio of 18.6000, with the industry PE ratio at 35.3139.

Dr Reddys Laboratories Ltd witnessed a -0.10% decrease in its share price, and it is currently trading at ₹1,276.60. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.6000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.10% drop, and it's now trading at ₹1,276.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd experienced a -0.07% downturn in its share price, and it's currently trading at ₹1,276.00. This situation is generating interest among value investors who are evaluating the stock's potential.

After a -0.07% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,276.00. The stock has a PE ratio of 18.6000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has dropped by -0.42%, a development that warrants careful analysis. Presently trading at ₹1,275.65, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.04% upswing, and it's currently trading at ₹1,280.10 per share. Investors are closely watching this development.

After a -0.55% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,278.80. The stock has a PE ratio of 18.6000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.90%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,287.80 per share.

Dr Reddys Laboratories Ltd stock price decreased by -0.32%, with the current market value at ₹1,276.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.